COVID-19: Patient Education Before Casirivimab and Imdevimab (FDA EUA)

Format:

Languages:

Physical Description: 
3 page handout
Description: 
Casirivimab and imdevimab are investigational medicines used to treat mild to moderate symptoms of COVID-19 in non-hospitalized adults and adolescents (12 years of age and older).
Keywords: 
covid EUA, COVID antibody, REGN-COV2, Coronavirus disease 2019, COVID-19, covid19, wuhan, COVID-19 test positive, Covid-19 drug, Covid-19 therapy, Casirivimab, Imdevimab, mAB, FDA, Emergency Use Authorization (EUA), Regeneron Pharmaceuticals
Publication or Revision Year: 
2020
Cover Sheet: 
Yes
Writing Team Contact: 
Lindsay Petty MD